HUE055468T2 - Új vegyület és gyógyszerészetileg elfogadható sója - Google Patents
Új vegyület és gyógyszerészetileg elfogadható sójaInfo
- Publication number
- HUE055468T2 HUE055468T2 HUE17885917A HUE17885917A HUE055468T2 HU E055468 T2 HUE055468 T2 HU E055468T2 HU E17885917 A HUE17885917 A HU E17885917A HU E17885917 A HUE17885917 A HU E17885917A HU E055468 T2 HUE055468 T2 HU E055468T2
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutically
- acceptable salt
- novel compound
- novel
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016251577 | 2016-12-26 | ||
| JP2017089251 | 2017-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE055468T2 true HUE055468T2 (hu) | 2021-11-29 |
Family
ID=62709343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE17885917A HUE055468T2 (hu) | 2016-12-26 | 2017-12-26 | Új vegyület és gyógyszerészetileg elfogadható sója |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10669283B2 (hu) |
| EP (1) | EP3560925B1 (hu) |
| JP (1) | JP6815417B2 (hu) |
| KR (1) | KR102414365B1 (hu) |
| CN (1) | CN110114358B (hu) |
| AU (1) | AU2017385199B2 (hu) |
| BR (1) | BR112019010571A2 (hu) |
| CA (1) | CA3048170A1 (hu) |
| CY (1) | CY1124643T1 (hu) |
| DK (1) | DK3560925T3 (hu) |
| ES (1) | ES2875548T3 (hu) |
| HU (1) | HUE055468T2 (hu) |
| IL (1) | IL267594B (hu) |
| MX (1) | MX2019007684A (hu) |
| PH (1) | PH12019501391A1 (hu) |
| PL (1) | PL3560925T3 (hu) |
| PT (1) | PT3560925T (hu) |
| RU (1) | RU2767878C2 (hu) |
| TW (1) | TWI752141B (hu) |
| UA (1) | UA124353C2 (hu) |
| WO (1) | WO2018124060A1 (hu) |
| ZA (1) | ZA201904241B (hu) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021155336A (ja) * | 2018-06-27 | 2021-10-07 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
| AR114977A1 (es) * | 2018-06-27 | 2020-11-11 | Meiji Seika Pharma Co Ltd | Cristales de derivado de benzoxazol |
| EP3815687A4 (en) * | 2018-06-27 | 2022-03-16 | Meiji Seika Pharma Co., Ltd. | THERAPEUTIC AGENT AGAINST INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES AND CANCER DISEASES |
| CA3138385A1 (en) | 2019-04-30 | 2020-11-05 | Aicuris Gmbh & Co. Kg | Novel indolizine-2-carboxamides active against the hepatitis b virus (hbv) |
| CN111057075B (zh) * | 2019-12-24 | 2021-04-27 | 武汉九州钰民医药科技有限公司 | Ret抑制剂及其制备方法 |
| JP7476431B2 (ja) | 2021-06-30 | 2024-04-30 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 二環性ピペラジン環を有するベンゾオキサゾール誘導体又はその塩の製造方法、並びに、その原料の製造方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61166827A (ja) | 1985-01-17 | 1986-07-28 | Toray Ind Inc | 変性エポキシ系微粒子 |
| JP3193560B2 (ja) * | 1993-04-16 | 2001-07-30 | 明治製菓株式会社 | 新規ベンゾオキサゾール誘導体 |
| JP3520177B2 (ja) | 1996-05-09 | 2004-04-19 | 明治製菓株式会社 | セロトニン５−ｈｔ３受容体部分活性薬 |
| GB0003256D0 (en) * | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
| RU2391341C2 (ru) * | 2002-09-25 | 2010-06-10 | Мемори Фармасьютиклз Корпорейшн | Индазолы, бензотиазолы, бензоизотиазолы, их получение и применение |
| NZ560969A (en) * | 2005-02-17 | 2010-08-27 | Albany Molecular Res Inc | Benzoxazole carboxamides for treating chemotherapy-induced vomiting and irritable bowel syndrome |
| AU2007281678B2 (en) * | 2006-08-07 | 2012-08-02 | Albany Molecular Research, Inc. | 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| ATE537175T1 (de) * | 2007-10-19 | 2011-12-15 | Boehringer Ingelheim Int | Neue piperazino-dihydrothienopyrimidin-derivate |
| ES2714705T3 (es) | 2013-07-10 | 2019-05-29 | Meiji Seika Pharma Co Ltd | Inhibidor de PDE4 novedoso |
-
2017
- 2017-12-26 US US16/473,507 patent/US10669283B2/en active Active
- 2017-12-26 TW TW106145711A patent/TWI752141B/zh active
- 2017-12-26 RU RU2019122999A patent/RU2767878C2/ru active
- 2017-12-26 DK DK17885917.9T patent/DK3560925T3/da active
- 2017-12-26 CA CA3048170A patent/CA3048170A1/en active Pending
- 2017-12-26 UA UAA201908271A patent/UA124353C2/uk unknown
- 2017-12-26 AU AU2017385199A patent/AU2017385199B2/en active Active
- 2017-12-26 EP EP17885917.9A patent/EP3560925B1/en active Active
- 2017-12-26 CN CN201780080389.7A patent/CN110114358B/zh active Active
- 2017-12-26 MX MX2019007684A patent/MX2019007684A/es unknown
- 2017-12-26 ES ES17885917T patent/ES2875548T3/es active Active
- 2017-12-26 KR KR1020197021334A patent/KR102414365B1/ko active IP Right Grant
- 2017-12-26 JP JP2018559513A patent/JP6815417B2/ja active Active
- 2017-12-26 WO PCT/JP2017/046610 patent/WO2018124060A1/ja unknown
- 2017-12-26 HU HUE17885917A patent/HUE055468T2/hu unknown
- 2017-12-26 PL PL17885917T patent/PL3560925T3/pl unknown
- 2017-12-26 BR BR112019010571A patent/BR112019010571A2/pt active Search and Examination
- 2017-12-26 PT PT178859179T patent/PT3560925T/pt unknown
-
2019
- 2019-06-18 PH PH12019501391A patent/PH12019501391A1/en unknown
- 2019-06-23 IL IL267594A patent/IL267594B/en unknown
- 2019-06-27 ZA ZA2019/04241A patent/ZA201904241B/en unknown
-
2021
- 2021-09-01 CY CY20211100780T patent/CY1124643T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2767878C2 (ru) | 2022-03-22 |
| PH12019501391A1 (en) | 2020-02-10 |
| UA124353C2 (uk) | 2021-09-01 |
| TWI752141B (zh) | 2022-01-11 |
| PL3560925T3 (pl) | 2021-12-20 |
| ES2875548T3 (es) | 2021-11-10 |
| IL267594B (en) | 2022-04-01 |
| WO2018124060A1 (ja) | 2018-07-05 |
| JP6815417B2 (ja) | 2021-01-20 |
| JPWO2018124060A1 (ja) | 2019-10-31 |
| RU2019122999A3 (hu) | 2021-03-31 |
| CN110114358B (zh) | 2021-12-03 |
| CA3048170A1 (en) | 2018-07-05 |
| US20190322686A1 (en) | 2019-10-24 |
| EP3560925A1 (en) | 2019-10-30 |
| AU2017385199A1 (en) | 2019-07-04 |
| DK3560925T3 (da) | 2021-06-28 |
| RU2019122999A (ru) | 2021-01-26 |
| CN110114358A (zh) | 2019-08-09 |
| KR102414365B1 (ko) | 2022-07-01 |
| AU2017385199B2 (en) | 2021-09-09 |
| CY1124643T1 (el) | 2022-11-25 |
| EP3560925A4 (en) | 2020-06-10 |
| TW201835080A (zh) | 2018-10-01 |
| KR20190097235A (ko) | 2019-08-20 |
| MX2019007684A (es) | 2019-09-09 |
| US10669283B2 (en) | 2020-06-02 |
| EP3560925B1 (en) | 2021-06-02 |
| ZA201904241B (en) | 2020-12-23 |
| PT3560925T (pt) | 2021-07-28 |
| BR112019010571A2 (pt) | 2019-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3466934T (pt) | Compostos de sulfonamida ou seus sais como inibidores da ribonucleótido-redutase para o tratamento de cancro | |
| HUE055468T2 (hu) | Új vegyület és gyógyszerészetileg elfogadható sója | |
| SG11201604954YA (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
| GB2569389B (en) | Compound | |
| GB2569388B (en) | Compound | |
| HK1257539A1 (zh) | 新的化合物及其用途 | |
| GB201721179D0 (en) | Compound | |
| GB201721178D0 (en) | Compound | |
| GB201721180D0 (en) | Compound | |
| GB201721172D0 (en) | Compound | |
| GB201701939D0 (en) | Salt | |
| GB201617103D0 (en) | Compound | |
| GB201612652D0 (en) | Novel compound | |
| LT3564230T (lt) | Pakeistas guanidino junginys | |
| GB201709565D0 (en) | Compound | |
| GB201610497D0 (en) | Compound | |
| GB201614224D0 (en) | Compounds and uses thereof | |
| IL268060B (en) | Phenyldifluoromethyl-substituted prolinamide compound | |
| GB201721673D0 (en) | Compound | |
| GB201721324D0 (en) | Compound | |
| GB201711900D0 (en) | Salt | |
| GB201711899D0 (en) | Salt | |
| GB201711901D0 (en) | Salt | |
| GB201619526D0 (en) | Compound | |
| GB201619531D0 (en) | Compound |